Basics Replimune Group, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $832.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.55 | 3.21% Avg Daily Range (30 D): $0.24 | 2.59% Avg Daily Range (90 D): $0.23 | 3.75% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): 2.09M Avg Daily Volume (90 D): 6.29M Trade Size Avg Trade Size (Sh.): 101 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 128 Institutional Trades Total Inst.Trades: 2,228 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $1.58M Avg Inst. Trade (90 D): $1.41M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.79M Avg Closing Trade (30 D): $2.02M Avg Closing Trade (90 D): $1.79M Avg Closing Volume: 126.5K     News Nov 7, 2025 @ 9:45 PM Replimune Presents Late-Breaking Abstract and Addi... Source: Replimune Group, Inc. Oct 20, 2025 @ 8:10 PM Why Replimune Stock Was Soaring Today Source: Eric Volkman Oct 20, 2025 @ 11:00 AM Replimune Announces FDA Acceptance of BLA Resubmis... Source: Sushil Patel, Ph.D., Ceo Of Replimune Oct 19, 2025 @ 12:00 PM Replimune Highlights Acral Melanoma Data for RP1 p... Source: Replimune Group, Inc. Sep 21, 2025 @ 3:20 PM REPL FINAL DEADLINE ALERT: Replimune (REPL) Shares... Source: Hagens Berman Financials   TTM Q2 2026 Q1 2026 Basic EPS $-3.46 $-.9 $-.95 Diluted EPS $-3.46 $-.9 $-.95 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -310.26M $ -83.1M $ -86.69M Operating Income / Loss $ -320.06M $ -84.29M $ -90.42M Cost of Revenue $ $ $ Net Cash Flow $ -11.2M $ 4.92M $ -13.74M PE Ratio     Splits Dec 01, 2010:   15:1